Entity Common Stock, Shares Outstanding of Monte Rosa Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Monte Rosa Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2025.
  • Monte Rosa Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2025 was 65.1M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)

Monte Rosa Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 65.1M Oct 31, 2025 10-Q 2025-11-06
Q2 2025 61.8M +387K +0.63% Aug 1, 2025 10-Q 2025-08-07
Q1 2025 61.5M +11.4M +22.6% Mar 17, 2025 10-K 2025-03-20
Q2 2024 61.4M Aug 5, 2024 10-Q 2024-08-08
Q1 2024 50.2M +795K +1.61% Mar 11, 2024 10-K 2024-03-14
Q3 2023 50.1M +1.68M +3.48% Nov 6, 2023 10-Q 2023-11-09
Q1 2023 49.4M +2.73M +5.85% Mar 10, 2023 10-K 2023-03-16
Q3 2022 48.4M +1.89M +4.07% Nov 7, 2022 10-Q 2022-11-10
Q2 2022 46.7M +332K +0.72% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 46.6M Mar 25, 2022 10-K 2022-03-29
Q3 2021 46.5M Nov 9, 2021 10-Q 2021-11-10
Q2 2021 46.4M Aug 10, 2021 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.